EUVIMEDEUVIMED entdecken
Crossref

FDA Advises Against Over-the-Counter Skin Lightening Products

Samantha Anderer

JAMA · 14.07.2026 · 336 (2) · 96

DOI: 10.1001/jama.2026.8311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 14.07.2026. Verfasst von Samantha Anderer.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Anderer, S. (2026). FDA Advises Against Over-the-Counter Skin Lightening Products. JAMA, 336(2), 96. https://doi.org/10.1001/jama.2026.8311

Vancouver

Anderer S. FDA Advises Against Over-the-Counter Skin Lightening Products. JAMA. 2026;336(2):96. doi:10.1001/jama.2026.8311

BibTeX
@article{Anderer2026,
  author = {Anderer, Samantha},
  title = {FDA Advises Against Over-the-Counter Skin Lightening Products},
  journal = {JAMA},
  year = {2026},
  volume = {336},
  number = {2},
  pages = {96},
  doi = {10.1001/jama.2026.8311}
}
Kostenlos starten →